top of page
Search

Monitoring Rheumatoid Arthritis: A Comprehensive Guide to Tracking Disease Progression - San Antonio TX Integrative & Functional Medicine


Living with rheumatoid arthritis (RA) means staying proactive—not just with treatment, but also with monitoring how the disease changes over time. RA is a chronic autoimmune condition that can lead to joint damage, disability, and systemic complications if not properly managed. Fortunately, ongoing monitoring can help detect flares early, assess treatment effectiveness, and guide important decisions.

Here’s a comprehensive guide to how RA is monitored based on current best practices.

1. Clinical Assessments

Joint Exams and Disease Activity Scores

Rheumatologists routinely perform physical exams to count swollen and tender joints, track morning stiffness, and evaluate joint function. These evaluations are often paired with standardized disease activity scores, such as:

  • DAS28 (Disease Activity Score 28)

  • CDAI (Clinical Disease Activity Index)

  • SDAI (Simplified Disease Activity Index)

These tools combine physical findings with lab markers and patient input. The goal is to reach low disease activity or remission, ideally with scores like DAS28 < 2.6 or CDAI ≤ 2.8.

Frequency

Stable patients are usually monitored every 3–6 months, while those with active disease or recent treatment changes may be seen more frequently.

2. Laboratory Testing

Inflammatory Markers

  • CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate) indicate inflammation.

  • These are monitored regularly to assess disease activity.

  • Vectra DA (MBDA Test): A multi-biomarker disease activity test measuring 12 proteins, hormones, and growth factors to provide a single score (1-100) reflecting RA inflammation. It’s personalized for age, gender, and body fat, predicting joint damage risk and treatment response. Low scores (<30) suggest lower risk of progression, while high scores (>44) indicate active disease. Useful for assessing flare risk and guiding therapy.

Autoantibodies

  • RF (Rheumatoid Factor) and Anti-CCP (Cyclic Citrullinated Peptide) are used for diagnosis and prognosis, but not ongoing monitoring.

Routine Safety Labs

  • CBC, liver enzymes, and kidney function tests are critical for monitoring side effects of RA medications, such as methotrexate or biologics.

3. Imaging Studies

X-rays

Used to detect joint erosion and damage, typically at baseline and then every 1–2 years.

Ultrasound and MRI

These can reveal early inflammation or structural damage not seen on X-rays. MRI is especially helpful in complex cases but is less commonly used due to cost.

4. Patient-Reported Outcomes

Tracking how patients feel and function is just as important as lab results.

Common Tools

  • HAQ-DI (Health Assessment Questionnaire Disability Index)

  • VAS (Visual Analog Scale) for pain, fatigue, and well-being

  • PROMIS tools for quality-of-life metrics

Self-Monitoring

  • Keeping a symptom diary or using apps like MyRA or ArthritisPower can help track flares, medication effects, and daily function.

5. Monitoring Treatment Response

Treat-to-Target Approach

RA management now emphasizes a “treat-to-target” strategy, where medications are adjusted until remission or low activity is reached.

Watch for Side Effects

  • Methotrexate may cause liver issues

  • Biologics can increase infection risk

  • NSAIDs may irritate the stomach

  • LDN generally safe from 0.1 mg to 4.5 mg but may cause liver issues at higher dose

6. Comorbidities and Lifestyle Factors

RA affects more than just joints.

  • Heart disease risk is elevated, so blood pressure, cholesterol, and glucose should be monitored.

  • Osteoporosis screening may be needed, especially with steroid use.

  • Mental health (anxiety and depression) should be screened regularly.

7. Working with Your Care Team

Rheumatology Follow-Up

Keep regular appointments (typically every 3–6 months) and communicate any changes.

Multidisciplinary Support

Physical therapists, occupational therapists, and nutritionists can help manage fatigue, joint pain, and daily challenges.

Practical Tips for Patients

  • Track symptoms consistently—apps or journals can help.

  • Stick to your medication plan—non-adherence is a leading cause of flares.

  • Report new symptoms early—don’t wait for your next visit.

  • Focus on whole-person wellness—healthy eating, movement, and stress reduction all support better outcomes.

When to Seek Immediate Help

Contact your healthcare provider if you experience:

  • Severe or persistent joint pain/swelling

  • New symptoms like fever or unexplained weight loss

  • Side effects like rash, nausea, or signs of infection

Final Thoughts

RA is a dynamic, lifelong condition—but with the right monitoring strategy, patients and providers can stay ahead of the disease. Whether through clinical scoring systems, lab work, imaging, or patient insights, ongoing monitoring is essential to keep inflammation under control and preserve quality of life.


If you’re navigating RA and unsure about how to track your progress, consider asking your provider about the tools and strategies mentioned here.


📘 Serving San Antonio TX Integrative & Functional Medicine Using LDN for Treatng Neuropathy, Brain Fog, Fatigue


Dr. Yoon Hang Kim, MD is a board-certified physician specializing in integrative functional medicine, dedicated to uncovering root causes and providing personalized healing for chronic and complex conditions. He is a recognized expert in Low Dose Naltrexone (LDN) for treating neuropathy, brain fog, and fatigue. He offers telemedicine services across multiple states—including Quincy, IL and throughout Illinois, San Antonio TX and all of Texas, Missouri, Florida, and Atlanta as well as the rest of Georgia.



 
 
 

Comments

bottom of page